Ligand validation:3AF4

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3AF4_GOL_A_317	47%	88%	0.153	0.89	0.35	0.32	-	-	1	0	100%	1
3AF4_GOL_A_325	33%	84%	0.232	0.91	0.4	0.36	-	-	2	0	100%	1
3AF4_GOL_A_318	32%	89%	0.221	0.897	0.38	0.25	-	-	0	0	100%	1
3AF4_GOL_A_324	32%	82%	0.229	0.903	0.36	0.44	-	-	0	0	100%	1
3AF4_GOL_A_319	27%	93%	0.197	0.846	0.37	0.13	-	-	0	0	100%	1
3AF4_GOL_A_322	23%	82%	0.309	0.936	0.36	0.44	-	-	0	0	100%	1
3AF4_GOL_A_321	22%	86%	0.272	0.888	0.37	0.34	-	-	0	0	100%	1
3AF4_GOL_A_314	21%	76%	0.222	0.828	0.35	0.6	-	-	3	0	100%	1
3AF4_GOL_A_315	7%	83%	0.464	0.934	0.31	0.46	-	-	0	0	100%	1
3AF4_GOL_A_316	7%	77%	0.294	0.747	0.42	0.5	-	-	0	0	100%	1
3AF4_GOL_A_320	4%	84%	0.383	0.746	0.36	0.41	-	-	0	0	100%	1
3AF4_GOL_A_323	3%	88%	0.529	0.851	0.36	0.31	-	-	0	0	100%	1
3AF4_GOL_A_326	2%	90%	0.342	0.648	0.35	0.26	-	-	0	0	100%	1
5XLV_GOL_A_423	71%	66%	0.121	0.942	0.5	0.81	-	-	2	0	100%	1
3AVQ_GOL_A_320	58%	88%	0.181	0.96	0.33	0.34	-	-	2	0	100%	1
3AF3_GOL_A_317	48%	92%	0.152	0.894	0.34	0.19	-	-	1	0	100%	1
3AF2_GOL_A_321	40%	79%	0.152	0.862	0.33	0.53	-	-	2	0	100%	1
3AEZ_GOL_A_316	40%	72%	0.224	0.935	0.28	0.79	-	-	0	0	100%	1
2NT0_GOL_D_506	100%	73%	0.016	0.997	0.3	0.72	-	-	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
3V5K_GOL_D_276	100%	96%	0.022	0.995	0.21	0.17	-	-	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.